ERAS and breast carcinoma: Brown and colleagues showed that ERα binding regions are highly enriched for the FOXA1 binding motif, and subsequently, FOXA1 was identified as an important pioneer factor for ER–chromatin interactions in ER-positive breast cancer cells [40] and as necessary for E2-mediated gene expression [39].